Yao Qian, Gao Linglin, Xu Teng, Chen Yun, Yang Xin, Han Mengmeng, He Xiaotao, Li Chengheng, Zhou Ruigang, Yang Yuhui
Hainan Key Laboratory of Tropical Animal Breeding and Disease Research, College of Animal Science and Technology, Hainan University, Haikou, China.
Front Microbiol. 2019 Jul 22;10:1638. doi: 10.3389/fmicb.2019.01638. eCollection 2019.
is a zoonotic pathogen that causes various life-threatening diseases. The mechanisms of action of amoxicillin against are unclear. Here, we established a rabbit tissue cage infection model to evaluate the relationship between the pharmacokinetic/pharmacodynamic (PK/PD) parameters of amoxicillin and selective enrichment of resistant strains of and to elucidate the evolution of its resistance to amoxicillin. was injected into the tissue cages at 10 colony forming units (CFU)/mL. We injected different intramuscular concentrations of amoxicillin at doses of 5, 10, 20, and 30 mg/kg body weight once a day for 5 days and 5, 10, 20, and 30 mg/kg body weight twice a day for 2.5 days. Differences in gene expression between two differentially resistant strains and a sensitive strain were evaluated using Illumina sequencing followed by COG and KEGG analysis. RT-qPCR was carried out to validate the difference in protein translation levels. Our results demonstrated that the emergence of resistant bacteria was dose dependent within a given time interval. In the same dosage group, the appearance of resistant bacteria increased with time. The resistant bacteria showed cumulative growth, and the level of resistance increased over time. The resistant bacteria were completely inhibited when the cumulative percentage of time over a 24-h period that the drug concentration exceeded the mutant prevention concentration (MPC) (% > MPC) was ≥52%. We also found that and in played a leading role in the development of resistance to amoxicillin. In conclusion, it provide references for optimizing amoxicillin regimens to treat infections caused by .
是一种可导致多种危及生命疾病的人畜共患病原体。阿莫西林对其作用机制尚不清楚。在此,我们建立了兔组织笼感染模型,以评估阿莫西林的药代动力学/药效学(PK/PD)参数与该病原体耐药菌株选择性富集之间的关系,并阐明其对阿莫西林耐药性的演变。将该病原体以10个菌落形成单位(CFU)/mL的浓度注入组织笼。我们每天一次以5、10、20和30mg/kg体重的剂量肌肉注射不同浓度的阿莫西林,持续5天;以及每天两次以5、10、20和30mg/kg体重的剂量注射,持续2.5天。使用Illumina测序,随后进行COG和KEGG分析,评估两种不同耐药菌株和一种敏感菌株之间基因表达的差异。进行RT-qPCR以验证蛋白质翻译水平的差异。我们的结果表明,在给定时间间隔内,耐药菌的出现呈剂量依赖性。在同一剂量组中,耐药菌的出现随时间增加。耐药菌呈累积生长,耐药水平随时间升高。当药物浓度超过突变预防浓度(MPC)的24小时内的累积时间百分比(%>MPC)≥52%时,耐药菌被完全抑制。我们还发现该病原体中的[具体基因1]和[具体基因2]在对阿莫西林耐药性的发展中起主导作用。总之,它为优化阿莫西林治疗该病原体引起的感染的方案提供了参考。